Modeling to improve TB decision-making in the United States

Location

Baltimore, Maryland, US

Dates

10/01/2014 - 09/01/2019

PI

David Dowdy, MD, PhD, ScM

We are part of a large consortium that is constructing epidemic and economic models of TB and HIV in collaboration with the U.S. CDC to improve decision-making for TB control in the USA.

People

Nicole C. Ammerman, PhD, ScM
Staff
Paul Converse, PhD
Emily Kendall, MD
Postdoctoral Fellows
Jacques Grosset, MD
Faculty
Kelly Dooley, MD, PhD
Faculty

Projects

RePORT India: c-TRIUMPh: Parent Protocol:...

Read More

ACTG trial A5343

Phase 2 safety study of bedaquiline and delamanid for the treatment of MDR-TB in South Africa

Read More

FlexDx-TB: A flexible, user-friendly model of...

We have developed a web-based model that allows decision-makers to input local epidemiological and economic values and receive...

Read More

Impact of diabetes on TB treatment outcomes...

This is a study to prospectively enroll and follow TB patients co-infected with diabetes and TB patients without diabetes...

Read More

The role of cell wall lipids in pathogenesis...

This study will use a combination of transcriptional, lipidomic, genetic, and imaging techniques to investigate whether...

Read More